¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"complex myoclonic epilepsy"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • localized epilepsy
    ±¹¼Ò°£Áú
  • major epilepsy
    ´ë°£Áú
  • minor epilepsy
    ¼Ò°£Áú
  • neonatal epilepsy
    ½Å»ý¾Æ°£Áú
  • nocturnal epilepsy
    ¾ß°£°£Áú
  • organic epilepsy
    ±âÁú¼º°£Áú
  • photic epilepsy
    ºûÀ¯¹ß°£Áú, ±¤À¯¹ß°£Áú
  • photogenic epilepsy
    ºûÀ¯¹ß°£Áú, ±¤À¯¹ß°£Áú
  • photosensitive epilepsy
    ºû¹Î°¨°£Áú, ±¤¹Î°¨°£Áú
  • post-apoplectic epilepsy
    ³úÁ¹ÁßÈİ£Áú
  • post-stroke epilepsy
    ³úÁ¹ÁßÈİ£Áú
  • post-traumatic epilepsy
    ¿Ü»óÈİ£Áú
  • psychomotor epilepsy
    Á¤½Å¿îµ¿°£Áú
  • petit mal epilepsy
    ¼Ò¹ßÀÛ°£Áú
  • running epilepsy
    ÁúÁÖ°£Áú
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • hysterical epilepsy
    È÷½ºÅ׸®°£Áú
  • idiopathic epilepsy
    Ư¹ß°£Áú
  • latent epilepsy
    Àẹ°£Áú
  • local epilepsy
    ±¹¼Ò°£Áú
  • major epilepsy
    ´ë°£Áú
  • masked epilepsy
    °¡¸é°£Áú
  • minor epilepsy
    ¼Ò°£Áú
  • morpheic epilepsy
    ¼ö¸éÇü°£Áú
  • neonatal epilepsy
    ½Å»ý¾Æ°£Áú
  • nocturnal epilepsy
    ¾ß°£°£Áú
  • organic epilepsy
    ±âÁú¼º°£Áú
  • petit mal epilepsy
    ¼Ò¹ßÀÛ°£Áú
  • photic epilepsy
    ±¤¼±°£Áú, ºûÀ¯¹ß°£Áú
  • photogenic epilepsy
    ±¤¼±°£Áú, ºûÀ¯¹ß°£Áú
  • photosensitive epilepsy
    ±¤¼±¹Î°¨°£Áú, ºû¹Î°¨°£Áú
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • postapoplectic epilepsy
    (³ú)Á¹ÁßÈİ£Áú(¡­ý­ÊÖòð).
  • postapoplectic epilepsy
    (³ú)Á¹ÁßÈİ£Áú((Òà)ðïñéý­ÊÖòð)
  • posttraumatic epilepsy
    ¿Ü»óÈÄ °£Áú.
  • posttraumatic epilepsy
    ¿Ü»óÈİ£Áú.
  • premenstrual epilepsy
    ¿ù°æÀü°£Áú (¡­ÊÖòð).
  • premenstrual epilepsy
    ¿ù°æÀü°£Áú(êÅÌèîñÊÖòð)
  • primary epilepsy
    ÀÏÂ÷¼º¡¡°£Áú
  • primary epilepsy
    ¿ø¹ß(¼º) °£Áú(ê«Û¡(àõ) ÊÖòð)
  • primary epilepsy
    ¿ø¹ß(¼º) °£Áú(ê«Û¡àõ ÊÖòð).
  • procursive epilepsy
    ÁúÁÖ¼º °£Áú(òðñËàõ ÊÖòð).
  • reactive epilepsy
    ¹ÝÀÀ¼º °£Áú(¡­ÊÖòð).
  • reactive epilepsy
    ¹ÝÀÀ¼º °£Áú(ÚãëëàõÊÖòð)
  • ARC => AIDS-related complex
    ÈÄõ¼º¸é¿ª°áÇÌÁõ°ü·ÃÁõÈıº
  • AlDS-related complex
    ÈÄõ¼º¸é¿ª°áÇÌÁõ°ü·ÃÁõÈıº
  • Eisenmengers complex
    ¾ÆÀÌÁ¨¸à°Åº¹ÇÕ.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • myoclonic seizure
  • myoclonic twitch
    ¹Ì¿ÀŬ·Î´©½º¾ç¿¬Ãà, °£´ë ¼º ±Ù°æ·Ã¾ç¿¬Ãà(¡­åÆÕýõê).
  • progressive myoclonic epilepsies
  • abdominal epilepsy
  • abortive epilepsy
    ºÎÀü°£Áú.
  • affect epilepsy
    Á¤µ¿¼º °£Áú(ï×ÔÑàõÊÖòð).
  • akinetic epilepsy
    ¹«µ¿¼º °£Áú(¡­ÊÖòð).
  • alcoholic epilepsy
    ¾ËÄڿüº °£Áú(¡­ÊÖòð).
  • arithmetical epilepsy
    »ê¼ú¼º °£Áú
  • autonomic epilepsy
    ÀÚÀ²½Å°æ°è °£Áú
  • benign partial epilepsy of childhood
    ¼Ò¾Æ±â ¾ç¼ººÎºÐ°£Áú
  • centrencephalic epilepsy
    Á߽ɳú¼º°£Áú(ñéãýÒààõÊÖòð).
  • childhood absence epilepsy
    ¼Ò¾Æ±â °á½Å¹ßÀÛ
  • cortical epilepsy
    ÇÇÁú(¼º)°£Áú(¡­ÊÖòõ).
  • cryptogenic epilepsy
    Àẹ¼º °£Áú.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • complex lipid
    º¹ÇÕÁöÁú(ÜÜùêò·òõ)
  • complex locus
    º¹ÇÕºÎÀ§(ÜÜùêÝ»êÈ)
  • complex medium
    º¹ÇÕ ¹è¾ç¾×(ÜÜùêÛÆå×äû)
  • complex oligosaccharides
    º¹ÇÕ(ÜÜùê) ¿Ã¸®°í»çÄ«¶óÀ̵å
  • complex RNA
    º¹ÇÕ(ÜÜùê) RNA
  • complex virion
    º¹ÇÕ(ÜÜùê) ºñ¸®¿Â
  • covalent enzyme-substrate complex
    È¿¼Ò±âÁú °øÀ¯°áÇÕü(ý£áÈÐñòõÍìêóÌ¿ùêô÷) (ÔÒ) enzymesubstrate compound
  • cytochrome c oxidase complex
    »çÀÌÅäÅ©·Ò c ¿Á½Ãµ¥À̽º º¹ÇÕü(ÜÜùêô÷) (ÔÒ) complex IV
  • dead-end complex
    Á¾¸»º¹ÇÕü(ðûØÇÜÜùêô÷)
  • enzyme-bridge complex
    È¿¼Ò°¡±³ º¹ÇÕü (ý£áÈÊ­ÎéÜÜùêô÷)
  • enzyme complex
    È¿¼Òº¹ÇÕü (ý£áÈÜÜùêô÷)
  • enzyme-inhibitor complex
    È¿¼Ò-ÀúÇØÁ¦ º¹ÇÕü (ý£áÈîÁúªð¥ÜÜùêô÷)
  • enzyme-substrate complex
    È¿¼Ò-±âÁú º¹ÇÕü (ý£áÈÐñòõÜÜùêô÷)
  • H-2 complex
    H-2 º¹ÇÕü(ÜÜùêô÷)
  • immune complex
    ¸é¿ª º¹ÇÕü(Øóæ¹ÜÜùêô÷)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
MTA malignant teratoma, anaplastic; medical technical assistant; medical technology assessment; metatars...
APSAC   1) Acylating the Plasminogen Streptokinase Activated Complex
  2) Anisoylat...
APSAC acylated plasminogen-streptokinase activator complex; anisoylated plasminogen streptokinase activato...
ARC accelerating rate calorimetry; acquired immunodeficiency syndrome-related complex; active renin conc...
MAC MacConkey [broth]; major ambulatory category; malignancy-associated changes; maximum allowable conce...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
Complex I complex
complex C complex
ADNFLE Autosomal dominant nocturnal frontal lobe epilepsy
BCECT Benign Childhood Epilepsy with Centrotemporal Spike
BRE Benign Rolandic Epilepsy
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • uncinate epilepsy
    ±¸È¸ °£Áú
  • acyl-plasminogen streptokinase activator complex
    ¾Æ½Ç-Çø®Áî¹Ì³ë°Õ½ºÆ®·¾ÅäŰ³ªÁ¦ Ȱ¼º
  • AIDS related complex
    AIDS °ü·Ã º¹ÇÕÁõ, ÈÄõ¼º ¸é¿ª °áÇÌÁõ°ú ¿¬°üµÈ Áúȯ, ÈÄõ¼º ¸é¿ª °áÇÌÁõ-°ü·Ã º¹ÇÕü, ÈÄõ¼º ¸é¿ª °áÇÌÁõ °ü·Ã º¹ÇÕ ¹ÝÀÀ
  • amylase complex with immunoglobulin
    ¸é¿ª ±Û·ÎºÒ¸° ¾Æ¹Ð¶óÁ¦ º¹ÇÕü
  • anti-inhibitor coagulation complex
    Ç×¾ïÁ¦Á¦ ÀÀ°í °áÇÕü
  • antibody-drug-cell complex
    Ç×ü ¾à¹° ¼¼Æ÷ º¹ÇÕü
  • antigen antibody complex
    Ç׿ø Ç×ü º¹ÇÕü
    Ç׿ø°ú Ç×ü°¡ °áÇÕÇÑ °Í. ¸é¿ª º¹ÇÕü¶ó°íµµ ÇÑ´Ù. Ç×ü´Â Ç׿ø°ú °áÇÕÇÏ¿© º¹ÇÕü¸¦ ¸¸µé¸é º¸Ã¼ Ȱ¼ºÈ­ ÀÛ¿ëÀ» °¡Áö°Ô µÈ´Ù. ±×·¡¼­ »ýü ³»¿¡¼­ ¸é¿ª º¹ÇÕü°¡ Çü¼ºµÇ¸é ±× ÁÖº¯¿¡¼­ ºÎü°¡ Ȱ¼ºÈ­µÇ¾î ¿°Áõ¹ÝÀÀÀ» ¹ß»ý½ÃŰ´Â ¼ÀÀÌ´Ù. Ç׿ø Ç×ü º¹ÇÕü´Â ħ°­¼ºÀÇ °ÍÀ¸·Î µÇ±â ½±´Ù. µû¶ó¼­ Ç׿øÀÇ Ä§ÀÔ ºÎÀ§¿¡ ¿°Áõ¹ÝÀÀÀÌ »ý±â±â ½±´Ù.
  • avian leukosis complex virus
    Á¶·ù ¹éÇ÷±¸Áõ ¹ÙÀÌ·¯½º
  • central renal echo complex
    ½Å Á᫐ ¿¡ÄÚ º¹ÇÕü
  • complex
    º¹Àâ, º¹ÇÕÀÇ
    com
  • complex cavity
    º¹À⠿͵¿, º¹ÇÕ ¿Íµ¿
    1. Ä¡¾ÆÀÇ ÇÑ ¸é ÀÌ»óÀ» Æ÷ÇÔÇÏ´Â ¿Íµ¿. Ä¡¾ÆÀÇ 2¸é ÀÌ»ó¿¡ °ÉÃÄ Çü¼ºµÈ ¿Íµ¿À¸·Î M.O, B.O, D.O, M.O.D ¿Íµ¿ µîÀÌ´Ù. 2. óġµÈ »óÅ¿¡¼­ Ä¡¾ÆÀÇ 3¸éÀÌ Ä§½ÀµÈ ¿ì½Ä º´¼Ò.
  • complex composite odontoma
    º¹ÇÕ Ä¡¾ÆÁ¾, º¹À⼺ Ä¡¾ÆÁ¾
  • complex crown fracture
    º¹Àâ Ä¡°ü ÆÄÀý
  • complex disorder
    º¹ÇÕ Àå¾Ö
  • complex fracture
    º¹Àâ °ñÀý
    ÁÖ¿ä Ç÷°ü, ½Å°æ, °üÀý µîÀÇ ÁÖÀ§ ÀÎÁ¢ ±¸Á¶¹°¿¡ ¼Õ»óÀ» ÁÖ´Â °ñÀý.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
generalised epilepsy A major category of epilepsy syndromes characterised by one or more types of generalised seizures.
(05 Mar 2000)
generalised tonic-clonic epilepsy tonic-clonic seizure
masked epilepsy A form of epilepsy characterised by a paroxysmal disturbance, such as headache or vomiting, associated with an epileptic electroencephalographic pattern.
(05 Mar 2000)
parietal lobe epilepsy A localization-related epilepsy where seizures originate within the parietal lobe. Seizure semiology may involve abnormalities of sensation.
(05 Mar 2000)
matutinal epilepsy A form of epilepsy which occurs on awakening.
(05 Mar 2000)
reflex epilepsy Seizures which are induced by peripheral stimulation; e.g., audiogenic, laryngeal, photogenic, or other stimulation.
Synonym: sensory precipitated epilepsy.
(05 Mar 2000)
partial epilepsy Epilepsy of various aetiologies characterised by focal seizures or secondarily generalised tonic-clonic seizures. Ictal symptoms are often related to the brain region where the seizure begins focally.
Synonym: cortical epilepsy, local epilepsy, partial epilepsy.
(05 Mar 2000)
visceral epilepsy Epilepsy, usually psychomotor, in which the attacks are initiated by visceral symptoms or sensations; most cases have their focus in the temporal lobe.
(05 Mar 2000)
pattern sensitive epilepsy A form of reflex epilepsy precipitated by viewing certain patterns.
(05 Mar 2000)
centrencephalic epilepsy An imprecise term referring to epilepsy characterised electroencephalographically by bilateral synchronous discharges, and clinically by absence or generalised tonic-clonic seizures.
(05 Mar 2000)
grand mal epilepsy Older term for epilepsy characterised by generalised tonic-clonic seizure.
(05 Mar 2000)
childhood absence epilepsy A generalised epilepsy syndrome characterised by the onset of absence seizures in childhood, typically at age six or seven years. There is a strong genetic predisposition and girls are affected more often than boys. EEG reveals generalised 3 Hz spike-wave activity on a normal background. Prognosis for remission is good if the patient does not also have generalised tonic-clonic seizures.
See: absence.
Synonym: petit mal epilepsy, pyknolepsy.
(05 Mar 2000)
childhood epilepsy with occipital paroxysms A benign epilepsy syndrome characterised by frequent occipital spikes often activated by eye closure. It has a seizure semiology that includes visual manifestations; not always remitting later in life.
(05 Mar 2000)
petit mal epilepsy A generalised epilepsy syndrome characterised by the onset of absence seizures in childhood, typically at age six or seven years. There is a strong genetic predisposition and girls are affected more often than boys. EEG reveals generalised 3 Hz spike-wave activity on a normal background. Prognosis for remission is good if the patient does not also have generalised tonic-clonic seizures.
See: absence.
Synonym: petit mal epilepsy, pyknolepsy.
(05 Mar 2000)
rolandic epilepsy A benign, autosomal, dominant form of epilepsy occurring in children, characterised clinically by arrest of speech, by muscular contractions of the side of the face and arm and epileptic discharges electroencephalographically.
Origin: Luigi Rolando
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • educationalindustrial complex
    ½ÅÇÐ ¿îµ¿
  • immune complex
    ¸é¿ª º¹ÇÕü
  • inferiority complex
    ¿­µî ÄÞÇ÷º½º;¿­µî°¨;¿­µîÀǽÄ;ÁÖ´ª;¿Ö°îµÈ ¸¶À½
  • launch complex
    ¹ß»ç½Ã¼³
  • military in dustrial complex
    ±º;»ê¾÷ º¹ÇÕü
  • persecution complex(mania)
    ÇÇÇØ(¹ÚÇØ)¸Á»ó
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á